0001193125-13-051316.txt : 20130212 0001193125-13-051316.hdr.sgml : 20130212 20130212144140 ACCESSION NUMBER: 0001193125-13-051316 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130212 DATE AS OF CHANGE: 20130212 GROUP MEMBERS: CRANSHIRE CAPITAL ADVISORS, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-35386 FILM NUMBER: 13596509 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KOPIN MITCHELL P CENTRAL INDEX KEY: 0001116628 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 3100 DUNDEE ROAD STREET 2: SUITE 703 CITY: NORTHBROOK STATE: IL ZIP: 60062 BUSINESS PHONE: 847 562-9030 MAIL ADDRESS: STREET 1: 3100 DUNDEE ROAD STREET 2: SUITE 703 CITY: NORTHBROOK STATE: IL ZIP: 60062 SC 13G/A 1 d482611dsc13ga.htm AMENDMENT #1 TO SCHEDULE 13G Amendment #1 to Schedule 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

CEL-SCI Corporation

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

150837409

(CUSIP Number)

December 31, 2012

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

a. x Rule 13d-1(b)

b. ¨ Rule 13d-1(c)

c. ¨ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

Page 1 of 6


CUSIP No. 150837409  

 

  1.   

Names of Reporting Persons.

 

Cranshire Capital Advisors, LLC

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  ¨

 

  3.  

SEC Use Only

 

  4.  

Citizenship or Place of Organization

 

    Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

    0

   6.   

Shared Voting Power

 

    16,160,614

   7.   

Sole Dispositive Power

 

    0

   8.   

Shared Dispositive Power

 

    16,160,614

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

    16,160,614 (see Item 4)

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

    4.99% (see Item 4)

12.  

Type of Reporting Person (See Instructions)

 

    OO; IA

 

 

Page 2 of 6


CUSIP No. 150837409  

 

  1.   

Names of Reporting Persons.

 

Mitchell P. Kopin

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        (b)  ¨

 

  3.  

SEC Use Only

 

  4.  

Citizenship or Place of Organization

 

    United States of America

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

    0

   6.   

Shared Voting Power

 

    16,160,614

   7.   

Sole Dispositive Power

 

    0

   8.   

Shared Dispositive Power

 

    16,160,614

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

    16,160,614 (see Item 4)

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

    4.99% (see Item 4)

12.  

Type of Reporting Person (See Instructions)

 

    IN; HC

 

 

Page 3 of 6


This Amendment No. 1 is being filed jointly by the Reporting Persons and amends the Schedule 13G initially filed by the Reporting Persons with the Securities and Exchange Commission (the “SEC”) on February 6, 2012 (the “Schedule 13G”).

 

Except as set forth below, all Items of the Schedule 13G remain unchanged. All capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Schedule 13G.

     
Item 2.           
Item 2 of the Schedule 13G is hereby amended to add the following information for updating:      
 

(a)

   Name of Person Filing      
 

(b)

   Address of Principal Business Office or, if none, Residence      
 

(c)

   Citizenship      
     This Schedule 13G is being filed on behalf of (i) Cranshire Capital Advisors, LLC, a Delaware limited liability company (“CCA”), and (ii) Mitchell P. Kopin, an individual who is a citizen of the United States of America (“Mr. Kopin,” together with CCA, the “Reporting Persons”).      
     CCA serves as the investment manager to each of (i) Cranshire Capital Master Fund, Ltd., a Cayman Islands exempted company (“Cranshire Capital Master Fund”), (ii) a managed account (“Managed Account 1”) and (iii) a second managed account (“Managed Account 2”). In such capacity, CCA exercises voting and investment power over the shares of Common Stock held for the account of each of Cranshire Capital Master Fund, Managed Account 1 and Managed Account 2. CCA is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940, as amended.      
Item 3.           
Item 3 of the Schedule 13G is hereby amended to add the following information for updating:      
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:      
  (a)    ¨    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
  (b)    ¨    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
  (c)    ¨    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
  (d)    ¨    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
  (e)    x    An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
  (f)    ¨    An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
  (g)    ¨    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
  (h)    ¨    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i)    ¨    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
  (j)    ¨    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
  (k)    ¨    Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:             

 

Page 4 of 6


Item 4.    Ownership.      
Item 4 of the Schedule 13G is hereby amended to add the following information for updating:      
   (a) and (b):      
     

As of the close of business on December 31, 2012, each of the Reporting Persons may be deemed to have beneficial ownership of 16,160,614 shares of Common Stock, which consists of (i) 1,211,000 shares of Common Stock held for the account of Cranshire Capital Master Fund, (ii) 427,002 shares of Common Stock issuable upon exercise of a warrant held by Cranshire Capital Master Fund (the “Master Fund Warrant”), (iii) 11,464,284 shares of Common Stock issuable upon exercise of a second warrant held by Cranshire Capital Master Fund (the “Second Master Fund Warrant”) and (iii) 3,058,328 shares of Common Stock issuable upon exercise of a third warrant held by Cranshire Capital Master Fund (the “Third Master Fund Warrant”), and all such shares of Common Stock represent beneficial ownership of approximately 4.99% of the Common Stock, based on (1) 308,910,390 shares of Common Stock issued and outstanding on December 31, 2012, as reported in the Form S-3/A filed by the Issuer on February 7, 2013, plus (2) 427,002 shares of Common Stock issuable upon exercise of the Master Fund Warrant, (3) 11,464,284 shares of Common Stock issuable upon exercise of the Second Master Fund Warrant, and (4) 3,058,328 shares of Common Stock issuable upon exercise of the Third Master Fund Warrant.

 

The foregoing excludes (I) 8,525,005 shares of Common Stock issuable upon exercise of the Third Master Fund Warrant because the Third Master Fund Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Third Master Fund Warrant to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates, and any other persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.99% of the Common Stock, (II) 11,700,000 shares of Common Stock issuable upon exercise of a fourth warrant held by Cranshire Capital Master Fund (the “Fourth Master Fund Warrant”) because the Fourth Master Fund Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Fourth Master Fund Warrant to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates, and any other persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.99% of the Common Stock, (III) 794,944 shares of Common Stock issuable upon exercise of a fifth warrant held by Cranshire Capital Master Fund (the “Fifth Master Fund Warrant”) because the Fifth Master Fund Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Fifth Master Fund Warrant to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates, and any other persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.9% of the Common Stock, (IV) 833,333 shares of Common Stock issuable upon exercise of a sixth warrant held by Cranshire Capital Master Fund (the “Sixth Master Fund Warrant”) because the Sixth Master Fund Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Sixth Master Fund Warrant to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates, and any other persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.9% of the Common Stock, (V) 535,716 shares of Common Stock issuable upon exercise of a warrant held by Managed Account 1 (the “Managed Account 1 Warrant”) because the Managed Account 1 Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Managed Account 1 Warrant to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates, and any other persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.99% of the Common Stock, (VI) 300,000 shares of Common Stock issuable upon exercise of a warrant held by Managed Account 2 (the “Managed Account 2 Warrant”) because the Managed Account 2 Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Managed Account 2 Warrant to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates, and any other persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.99% of the Common Stock, and (VII) 416,667 shares of Common Stock issuable upon exercise of a second warrant held by Managed Account 2 (the “Second Managed Account 2 Warrant”) because the Second Managed Account 2 Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Second Managed Account 2 Warrant to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates, and any other persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may be deemed to have beneficial ownership of 39,266,279 shares of Common Stock.

     
   (c)    Number of shares as to which each Reporting Person has:      
      (i)    Sole power to vote or to direct the vote:      
         0.      
      (ii)    Shared power to vote or to direct the vote:      
         16,160,614.      
      (iii)    Sole power to dispose or to direct the disposition of      
         0.      
      (iv)    Shared power to dispose or to direct the disposition of      
         16,160,614.      

Item 5.

   Ownership of Five Percent or Less of a Class      
  

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following x.

     
Item 10.    Certification      
  

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

 

Page 5 of 6


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 12 , 2013

 

CRANSHIRE CAPITAL ADVISORS, LLC

By:

 

/s/ Mitchell P. Kopin

  Mitchell P. Kopin, Managing Member

/s/ Mitchell P. Kopin

Mitchell P. Kopin

 

Page 6 of 6